Souleymane Dela Sacko

Recent publications · Crossref

5 total works indexed

1. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

   · 2017 · cited 3,595x

2. Longitudinal analyses reveal immunological misfiring in severe COVID-19

   · 2020 · cited 1,929x

3. Lung Cancer 2020

   · 2020 · cited 1,663x

4. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

   · 2021 · cited 1,520x

5. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)

   · 2020 · cited 1,279x

via Crossref · CC0